Scinovex
review Open AccessTop 1% cited

mTOR Signaling in Growth Control and Disease

Cell · 2012 · Vol. 149(2) · pp. 274–293
Mathieu LaplanteDavid M. Sabatini
PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and CancerProtein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR pathwayBiologyNeurodegenerationMechanistic target of rapamycinSignal transductionDiseaseNeuroscienceProtein kinase BCell biologyBioinformatics

MeSH terms

AnimalsHumansMetabolic DiseasesNeoplasmsStem CellsSignal TransductionNeurodegenerative DiseasesTOR Serine-Threonine Kinases

Funding

  • National Institutes of Health
  • Canadian Institutes of Health Research
Citations
8,373
FWCI
265.52
field-weighted impact
References
181
Percentile
100%
vs. same field & year
Citations per year
Cited by
mTOR: a pharmacologic target for autophagy regulation
Journal of Clinical Investigation · 2015 · 2,079 citations
Fundamentals of cancer metabolism
Science Advances · 2016 · 2,929 citations
Mechanisms of Insulin Action and Insulin Resistance
Physiological Reviews · 2018 · 2,790 citations
Autophagy in malignant transformation and cancer progression
The EMBO Journal · 2015 · 1,149 citations
The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
Gynecologic Oncology · 2015 · 409 citations
PI3K and cancer: lessons, challenges and opportunities
Nature Reviews Drug Discovery · 2014 · 1,716 citations
From Krebs to clinic: glutamine metabolism to cancer therapy
Nature reviews. Cancer · 2016 · 2,092 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.